[(1R,3S,7S,8E,11S,12S,13E,17R,21S,23S)-11,21-dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate

InChIKey	`RSTWARDIGORXQU-JAGFQYIRSA-N`
Compound Name	[(1R,3S,7S,8E,11S,12S,13E,17R,21S,23S)-11,21-dihydroxy-17-[(1R)-1-hydroxyethyl]-13-(2-methoxy-2-oxoethylidene)-10,10-dimethyl-19-oxo-6,18,27,28,29-pentaoxatetracyclo[21.3.1.13,7.111,15]nonacos-8-en-12-yl] octanoate
Canonical SMILES	`CCCCCCCC(=O)O[C@H]1/C(=C/C(=O)OC)CC2C[C@H]([C@@H](C)O)OC(=O)C[C@@H](O)C[C@@H]3CCC[C@H](C[C@@H]4CCO[C@H](/C=C/C(C)(C)[C@]1(O)O2)O4)O3`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	6.73
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	7.2	pIC50	TTD_MultiTarget
Q04759	PRKCQ	Homo sapiens	Human	PF00130 PF21494 PF00069 PF00433	6.8	Ki	ChEMBL;BindingDB
Q05655	PRKCD	Homo sapiens	Human	PF00130 PF21494 PF00069 PF00433	6.8	Ki	ChEMBL;BindingDB
P05771	PRKCB	Homo sapiens	Human	PF00130 PF00168 PF00069 PF00433	6.5	Ki	ChEMBL;BindingDB
Q02156	PRKCE	Homo sapiens	Human	PF00130 PF00168 PF00069 PF00433	6.3	Ki	ChEMBL;BindingDB